Lu Peng, President of Pharvaris N.V., Sells 15,000 Shares at $40.68 Each

Lu Peng, President of Pharvaris N.V. (PHVS), sold 15,000 shares at $40.68 each for a total of $610,134 on September 9, 2026.

Who is Lu Peng and What is His Real Role at Pharvaris N.V.?

Lu Peng serves as the President of Pharvaris N.V., a publicly traded company in the pharmaceutical sector. In this role, he oversees the company's global strategy, major operational decisions, and investor relations. As a top executive, he has access to material non-public information, including financial data, research projects, and market forecasts.

As the President of Pharvaris N.V., Lu Peng is considered an "insider" under U.S. regulations. Insiders are required to disclose all transactions involving their company's securities to ensure transparency for shareholders. These disclosures are made through the SEC Form 4, which must be filed within two business days of the transaction.

Under SEC requirements, every stock transaction by a director or officer must be recorded in the public registry. This mandate aims to prevent insider trading abuses and allows investors to track the actions of those with the most access to material company information.

Transaction Details: 15,000 Shares at $40.68 Each

On September 9, 2026, Lu Peng sold exactly 15,000 shares of Pharvaris N.V. at a price of $40.68 per share. The total amount of the transaction was calculated by multiplying the number of shares by the per-share price, resulting in $610,134.

It is important to distinguish between the per-share price and the total value. The $40.68 figure represents the cost of a single share, while $610,134 reflects the total proceeds received by the President from this sale.

The transaction was recorded in the SEC Form 4, available on the SEC's EDGAR website. The filing was made within the two-day deadline required by regulations, ensuring timely availability of the information to the market.

Why Insiders Sell Their Shares – Possible Reasons

Selling shares by an insider may stem from a desire to diversify their portfolio. Holding a significant stake in one company exposes them to concentrated risk, and reducing this exposure can be driven by a risk management strategy.

Tax considerations may also play a role. Realizing capital gains or recovering liquidity before the end of a fiscal year can optimize tax liability. Executives often plan their sales around tax deadlines to minimize tax impact.

Personal liquidity needs, such as funding real estate projects, settling estates, or covering large expenses, may prompt converting part of their equity into cash. This motivation does not necessarily indicate a lack of confidence in the company's prospects.

Lastly, the sale may be perceived as a bearish signal by the market, especially when coming from a senior executive. However, it is important to note that the exact reason remains unknown and could be entirely personal or driven by external constraints.

How Individual Investors Track Form 4 Filings

The SEC's EDGAR website provides free access to all filed forms, including the Form 4. By searching for the ticker PHVS or the insider's name, investors can download the original document and review the details of each transaction.

Third-party platforms aggregate this data and offer real-time alerts for significant transactions. Free tools like OpenInsider or WhaleWisdom allow filtering sales or purchases by amount, role, or date, facilitating insider trading surveillance.

It is important to remember that Form 4 filings only describe the nature of the transaction, not the underlying reasons or the company's future performance expectations. Therefore, investors should cross-reference this data with other fundamental analysis sources.

By combining Form 4 monitoring with financial statement reviews, press releases, and sector analyses, individual investors can gain a more comprehensive understanding of the context surrounding an insider's transaction.